Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Barclays analyst Luke Sergott maintains Quest Diagnostics (NYSE:DGX) with a Overweight and raises

Eastern Bank boosted its stake in Quest Diagnostics Incorporated (NYSE: DGX) by 9.3% during the thir

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies

Test showed 100% specificity, with no false-positive results in the cohort, at both 3- and 5-year fo

DGX's 36.3% YTD rise reflects momentum in advanced diagnostics, channel growth, AI adoption and cost

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Quest Diagnostics Incorporated's recurring testing demand provides a foundation for growth through h

SECAUCUS, N.J., Sept. 22, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader

Medicare and Medicaid have been overpaying Quest Diagnostics for years, says the government. Startin

DGX study finds nearly one-third of Lyme-seropositive patients had antibodies to another tick-borne

Quest Diagnostics gains momentum from customer wins, advanced diagnostics and AI initiatives, while

CMS proposes 2027 Medicare lab rates, estimating $1 billion in annual taxpayer savings as payments a

U.S. stock futures were mixed. Ericsson fell 4.3% after a Morgan Stanley downgrade; Quest Diagnostic

Vicor jumped 11% premarket after raising Q3 growth guidance above 20%; TOPS, FBGL and QNME led other

Quest Diagnostics (NYSE: DGX) CEO and President Jim Davis said the diagnostic testing company is exc

Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's

Quest Diagnostics NYSE: DGX CEO and President Jim Davis said the diagnostic testing company is excee

Truist Securities analyst David Macdonald maintains Quest Diagnostics (NYSE:DGX) with a Hold and

New study by researchers from Quest Diagnostics (NYSE:DGX) and the University of North Carolina at C

Study published in JAMA Network Open of over 193,000 patients nationwide reveals that individuals wi

Corient Private Wealth LP decreased its position in Quest Diagnostics Incorporated (NYSE: DGX) by 13

Fed hikes rates and signals another, putting MGEE, ADM, DOLE and DGX in focus as low-beta defensive

Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? W

75% of registered voters surveyed call diagnostic testing "very important" to their care, and a  bip

Quest Diagnostics Incorporated (NYSE: DGX - Get Free Report)'s stock price hit a new 52-week high on

Quest Diagnostics Incorporated (DGX) Presents at 2026 Global Healthcare Conference Transcript

The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi p

UBS analyst Kevin Caliendo maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the p

Test to join the company's expansive portfolio of Quest AD-Detect® blood tests for assessing sym

JP Morgan analyst Lisa Gill maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the

Mizuho analyst Ann Hynes maintains Quest Diagnostics (NYSE:DGX) with a Outperform and raises the

Truist Securities analyst David Macdonald maintains Quest Diagnostics (NYSE:DGX) with a Hold and

Barclays analyst Luke Sergott maintains Quest Diagnostics (NYSE:DGX) with a Overweight and raises

Baird analyst Eric Coldwell maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the

Quest Diagnostics (NYSE: DGX) stock jumps after Q2 earnings beat estimates and full-year 2026 guidan

U.S. stocks were down as Dow Jones fell 450 points on Thursday. Lockheed Martin (LMT) shares rose 11

Quest Diagnostics (NYSE:DGX) reported second-quarter financial results on Thursday. The transcript f

Companies Reporting Before The Bell • Altisource Portfolio (NASDAQ:ASPS) is estimated to report quar

Quest Diagnostics (NYSE:DGX) raises FY2026 Adj EPS guidance from $10.63-$10.83 to $11.05-$11.25 vs $

Quest Diagnostics (NYSE:DGX) raises FY2026 GAAP EPS guidance from $9.58-$9.78 to $9.97-$10.17 vs $9.

Quest Diagnostics (NYSE:DGX) reported quarterly earnings of $3.12 per share which beat the analyst c

Baird analyst Eric Coldwell maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the

Quest Diagnostics® (NYSE:DGX), a leading provider of diagnostic information services, today announce

UBS analyst Kevin Caliendo maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the p

Quest Diagnostics (DGX) reported strong Q1 earnings, beating expectations and raising guidance. Anal

Baird analyst Eric Coldwell maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the

Barclays analyst Luke Sergott maintains Quest Diagnostics (NYSE:DGX) with a Overweight and raises

Truist Securities analyst David Macdonald maintains Quest Diagnostics (NYSE:DGX) with a Hold and

Quest Diagnostics Q1 revenue grew 9.2% as organic volume surged. Discover how new partnerships and A